Kiin Bio Weekly
Subscribe
Sign in
Home
Podcast
Weekly Newsletter
About
Talus Bio's Ptarmigan-1, the Human Cancer Models Initiative, and Vilya Research's Vilya-2
Kiin Bio's Weekly Insights
READ THE LATEST
Weekly Newsletter
View all
Talus Bio's Ptarmigan-1, the Human Cancer Models Initiative, and Vilya Research's Vilya-2
Kiin Bio's Weekly Insights
Aug 6
•
Natasha Kilroy
2
NYGC's Pan-human Azimuth, Zheng Lab's AAMFM, and Meijers Lab's ML-aided antibody platform
Kiin Bio's Weekly Insights
Jul 30
•
Natasha Kilroy
2
Stanford's scVision, Ohio State's conDitar-dev, and the AllTheBacteria consortium
Kiin Bio's Weekly Insights
Jul 23
•
Natasha Kilroy
1
Vilya Research's Vilya-1, TU Munich's TWIN, and Stanford's UCE
Kiin Bio's Weekly Insights
Jul 16
•
Natasha Kilroy
1
Deep Dive
View all
Savana: Turning Clinical Text into Regulatory-Grade Evidence
Deep Dive | Edition 23
Aug 4
•
Natasha Kilroy
1
MolJSON: Teaching Language Models to Speak Molecule
Deep Dive | Edition 22
Jul 21
•
Natasha Kilroy
3
Scigantic: The Platform That Democratizes Access to Large-Scale Data
Deep Dive | Edition 21
Jul 14
•
Natasha Kilroy
3
2
🧬 scConcept: Why Your Cell Embeddings Don't Work
Deep Dive | Edition 20
May 20
•
Natasha Kilroy
3
Primer
View all
A Primer on Market Access
Why drugs miss commercial forecasts, and what earlier alignment between clinical and market access teams could fix
Jul 28
•
Natasha Kilroy
1
A Primer on Molecular Docking
Why docking scores don’t predict binding affinity, and what template-guided approaches actually deliver
Jun 23
•
Natasha Kilroy
1
1
A Primer on the Comp Bio Career Landscape
Salaries, skills, and hiring data from 2,000+ UK listings and a specialist recruiter
Jun 9
•
Natasha Kilroy
11
A Primer on Clinical AI 🏥
Close to 1,500 FDA-approved AI use cases, meta-analyses proving cost-effectiveness, and hospitals still aren't adopting.
May 26
•
Natasha Kilroy
2
1
Podcast
View all
17:20
Introducing Chai-2: A Breakthrough Framework for Zero-Shot Antibody Design
What’s slowing you down?
Jul 9, 2025
•
Kiin Bio
2
1
22:45
FutureHouse Introduces ether0: A Chemistry Reasoning Model for Molecular Design
FutureHouse has developed ether0, a 24B-parameter reasoning language model that solves complex chemistry problems by generating explicit, step-by-step…
Jun 6, 2025
2
1
19:14
Introducing Virtual Cells by Recursion: A New Framework for Predictive and Explainable Drug Discovery
Introducing Virtual Cells: A New Framework for Predictive and Explainable Drug Discovery
Jun 5, 2025
3
1
22:54
Introducing Robin: A Multi-Agent System for Automated Drug Discovery
Before we start … we are hiring for a few positions (bioinformatician, cheminformaticia, software engineer)!
May 22, 2025
5
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
